Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26467790 | 0.92 | SMN1; SMN2 (0.47) | ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1 | |
| SCHEMBL22815777 | 0.91 | ALOX15 (0.47) | ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1 | |
| SCHEMBL21296900 | 0.90 | CYP19A1 (0.57) | ALOX15L3MBTL1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL21296928 | 0.90 | ALOX15 (0.49) | ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1 | |
| SCHEMBL26467846 | 0.90 | ALOX15 (0.49) | ALOX15L3MBTL1MEN1KMT2APOLB | |
| SCHEMBL23319902 | 0.89 | MEN1 (0.60) | ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1 | |
| SCHEMBL22815603 | 0.84 | ALOX15 (0.49) | ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1 | |
| SCHEMBL24155170 | 0.84 | NPBWR1 (0.50) | ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1 | |
| SCHEMBL23320004 | 0.82 | KCNH2 (0.50) | ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1 | |
| SCHEMBL28543421 | 0.82 | ALDH1A1 (0.48) | ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4087836-B1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | CANTERO THERAPEUTICS INC (US) | 2025-10-08 | — | — | EP | disclosed |
| CN-114945559-B | Preparation method of triazole glycollic acid oxidase inhibitor | 坎特罗治疗有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-112399873-B | Triazole glycolate oxidase inhibitors | 坎特罗治疗有限公司 | 2024-10-25 | — | — | CN | disclosed |
| US-20230143491-A1 | TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | PHOENIX TISSUE REPAIR, INC. | 2023-05-11 | — | — | US | disclosed |
| US-20230143491-A1 | TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | PHOENIX TISSUE REPAIR, INC. | 2023-05-11 | — | — | US | disclosed |
| US-20230143491-A1 | TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | PHOENIX TISSUE REPAIR, INC. | 2023-05-11 | — | — | US | disclosed |
| US-20230129160-A1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | PHOENIX TISSUE REPAIR, INC. | 2023-04-27 | — | — | US | disclosed |
| US-20230129160-A1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | PHOENIX TISSUE REPAIR, INC. | 2023-04-27 | — | — | US | disclosed |
| EP-4087836-A1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | Cantero Therapeutics, Inc. (US) | 2022-11-16 | — | — | EP | disclosed |
| CN-114945559-A | Preparation method of triazole glycolate oxidase inhibitor | 坎特罗治疗有限公司 | 2022-08-26 | — | — | CN | disclosed |
| US-11401246-B2 | Triazole glycolate oxidase inhibitors | Cantero Therapeutics, Inc. (US) | 2022-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11401246-B2 | Triazole glycolate oxidase inhibitors | XDH, DUOX1, PNPO | ALOX15 71/4885L3MBTL1 2586/4885CYP1A2 179/4885 |
| US-20230143491-A1 | TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | XDH, DUOX1, PNPO | ALOX15 71/4885L3MBTL1 2586/4885CYP1A2 179/4885 |
| US-20230129160-A1 | PROCESSES FOR PREPARING TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | TH, AOX1, AOC3 | ALOX15 510/4885L3MBTL1 4348/4885CYP1A2 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.